BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 26455479)

  • 1. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
    Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
    Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
    Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
    Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of baicalin on allergic response in ovalbumin-induced allergic rhinitis guinea pigs and lipopolysaccharide-stimulated human mast cells.
    Zhou YJ; Wang H; Sui HH; Li L; Zhou CL; Huang JJ
    Inflamm Res; 2016 Aug; 65(8):603-12. PubMed ID: 27043920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells.
    Yamauchi Y; Fujikura T; Shimosawa T
    Allergol Int; 2007 Jun; 56(2):171-7. PubMed ID: 17460445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of desloratadine citrate disodium injection on rat models of ovalbumin-induced allergic rhinitis: involvement of T-cell responses modulation.
    Yuan X; Ghosh A; Jie Q; He G; Wu Y
    Int Forum Allergy Rhinol; 2015 Dec; 5(12):1170-6. PubMed ID: 26155922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpheniramine attenuates histamine-mediated aquaporin 5 downregulation in human nasal epithelial cells via suppression of NF-κB activation.
    Chang YL; Lin CS; Wang HW; Jian KR; Liu SC
    Int J Med Sci; 2017; 14(12):1268-1275. PubMed ID: 29104484
    [No Abstract]   [Full Text] [Related]  

  • 7. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
    Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
    Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades.
    Matsubara M; Tamura T; Ohmori K; Hasegawa K
    Biochem Pharmacol; 2005 Feb; 69(3):433-49. PubMed ID: 15652235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine.
    Di Sciascio MB; Vianale G; Verna N; Petrarca C; Perrone A; Toniato E; Muraro R; Conti P; Di Gioacchino M
    Int J Immunopathol Pharmacol; 2007; 20(4):745-51. PubMed ID: 18179747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tussilagone inhibits allergic responses in OVA-induced allergic rhinitis guinea pigs and IgE-stimulated RBL-2H3 cells.
    Jin C; Ye K; Luan H; Liu L; Zhang R; Yang S; Wang Y
    Fitoterapia; 2020 Jul; 144():104496. PubMed ID: 32058052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effect of curcumin on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse.
    Zhang N; Li H; Jia J; He M
    Cell Immunol; 2015; 298(1-2):88-95. PubMed ID: 26507910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
    Piao CH; Song CH; Lee EJ; Chai OH
    Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallergic effect of gami-hyunggyeyeongyotang on ovalbumin-induced allergic rhinitis in mouse and human mast cells.
    Im YS; Lee B; Kim EY; Min JH; Song DU; Lim JM; Eom JW; Cho HJ; Sohn Y; Jung HS
    J Chin Med Assoc; 2016 Apr; 79(4):185-94. PubMed ID: 26852212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
    Bui TT; Piao CH; Song CH; Chai OH
    Int Immunopharmacol; 2017 Nov; 52():77-84. PubMed ID: 28886581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.
    Kamekura R; Kojima T; Takano K; Go M; Sawada N; Himi T
    Clin Exp Allergy; 2012 Feb; 42(2):218-28. PubMed ID: 22233535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic effect of KOB03, a polyherbal medicine, on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse and human mast cells.
    Won Jung H; Jung JK; Weon Cho C; Kang JS; Park YK
    J Ethnopharmacol; 2012 Aug; 142(3):684-93. PubMed ID: 22687252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic efficacy of α-pinene in an experimental mouse model of allergic rhinitis.
    Nam SY; Chung CK; Seo JH; Rah SY; Kim HM; Jeong HJ
    Int Immunopharmacol; 2014 Nov; 23(1):273-82. PubMed ID: 25242385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis.
    Zhao Y; van Hasselt CA; Woo JK; Chen GG; Wong YO; Wang LH; Leung PC
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):844-50. PubMed ID: 16802773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.
    Rudack C; Steinhoff M; Mooren F; Buddenkotte J; Becker K; von Eiff C; Sachse F
    Clin Exp Allergy; 2007 Jul; 37(7):1009-22. PubMed ID: 17581194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.